Carrier Screening Market by Product and Service, Type (Expanded (Customized, Predesigned) Targeted Diseases, Medical condition (Hematologic, Pulmonary), Technology (DNA Sequencing, PCR), End user, Region - Global Forecast to 2028

Carrier Screening Market by Product and Service, Type (Expanded (Customized, Predesigned) Targeted Diseases, Medical condition (Hematologic, Pulmonary), Technology (DNA Sequencing, PCR), End user, Region - Global Forecast to 2028



The global Carrier Screening Market is expected to reach USD 5.4 Billion by 2028 from USD 2.2 Billion in 2023, at a CAGR of 19.7% during the forecast period. Market is driven by factors such as Ongoing advancements in genetic testing technologies, such as next-generation sequencing (NGS), improve the efficiency, accuracy, and cost-effectiveness of carrier screening, The increasing prevalence of genetic disorders, coupled with a greater understanding of the genetic basis of various conditions On the other hand, The demand for genetic counseling services often exceeds the available resources. A shortage of genetic counselors can hinder the delivery of comprehensive counseling to individuals undergoing carrier screening, potentially limiting the understanding and interpretation of results.

“The Neurological Conditions accounted for the second largest market share in the carrier screening market product’ s market, during the forecast period”

Based on the Medical Conditions, Carrier Screening Market is classified into Hematologic Conditions, Pulmonary Conditions, Neurological Conditions, and Others. In 2022, Neurological Conditions accounted for a sizable market share because Many neurological disorders have a genetic component. Understanding the genetic basis of conditions such as Huntington's disease, amyotrophic lateral sclerosis (ALS), and certain forms of epilepsy can be crucial for assessing the risk of passing on these conditions to future generations. Likewise, Carrier screening for neurological conditions allows for early detection of genetic risk factors. Early identification of carriers provides an opportunity for individuals and couples to make informed reproductive decisions and consider interventions or therapies early in the planning stages.

“PCR technology segment accounted for the second largest market share”

Based on type on technology, the carrier screening market is segmented into DNA Sequencing, PCR, DNA Microarray, and Other. The PCR technology segment accounted for the second largest market share in 2022., due to its variety of applications such as PCR technology is known for its high sensitivity and specificity in amplifying and detecting specific DNA sequences. This accuracy is crucial in carrier screening to reliably identify carriers of genetic mutations associated with various disorders, likewise, PCR allows for the amplification of multiple target DNA sequences in a single reaction, a feature known as multiplexing. This capability is valuable in carrier screening,

“APAC region accounted for the third highest CAGR”

The global Carrier Screening market is divided into four regions: North America, Asia-Pacific, Europe, and Rest of the World. According to the regional analysis, the Asia-Pacific region is likely to retain a considerable market share in 2022 and the future. The Asia-Pacific market is being propelled by an rising cases of rare disease, rising in healthcare expenditure, rising in awareness about early disease diagnosis.

“Europe is estimated to register the second highest CAGR during the forecast period.”

In this report, the Carrier Screening market is segmented into four major regional segments: North America, Europe, Asia Pacific, Rest of the world. The market in Europe is projected to register the second highest growth rate during the forecast period. The growth in this market is due to Europe has a strong tradition of research and academic excellence, the rising incidence of genetic and rare diseases, government funding for research and healthcare in many European countries supports the development and adoption of advanced diagnostic technologies such as carrier screening.

The primary interviews conducted for this report can be categorized as follows:

By Company Type: Tier 1 - 32%, Tier 2 - 44%, and Tier 3 - 24%

By Designation: C-level - 30%, D-level - 34%, and Others - 36%

By Region: North America - 40%, Europe - 28%, Asia Pacific - 20%, and the Rest of the World – 12%

Lits of Companies Profiled in the Report:

Invitae Corporation. (US)

Fulgent Genetics.(US)

Eurofins Scientific (Germany)

OPKO Health, Inc.(US)

Thermo Fisher Scientific Inc.(US)

Quest Diagnostics Incorporated (US)

Myriad Genetics, Inc (US)

Illumina, Inc.(US)

Natera, Inc.(Italy)

Laboratory Corporation of America Holdings.(US)

CENTOGENE N.V.(Germany)

DiaSorin S.p.A.(Italy)

BGI (China)

Otogenetics (US)

GeneTech (India)

Signature Diagnostics Inc.(US)

MedGenome (US)

Ambry Genetics.(US)

Asper Biogene (Estonia)

LifeLabs Genetics (Canada)

EasyDNA (US)

LifeCell (India)

CNC Path Lab (India)

Oxy-Gen Laboratory LLC (US)

Mitera (US)

Research Coverage:

This report studies the Carrier Screening market based on Product & Service, Type, Medical Condition, Technology, End User, and Region. The report also analyses factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total Carrier Screening market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

Market Drivers: Comprehensive information about driving factors of the markets. The report analyses the markets drivers across key geographic regions.

Market Penetration: Comprehensive information on Carrier Screening Market products offered by the top 25 players in the market. The report analyses the Carrier Screening market by Product & Service, Type, Medical Condition, Technology, End User, and Region.

Market Development: Comprehensive information about lucrative emerging markets. The report analyses the markets for various securement devices across key geographic regions.

Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the Carrier Screening market

Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the Carrier Screening market

Market Position: It will upkeep stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies.


  • INTRODUCTION
    • STUDY OBJECTIVES
    • MARKET DEFINITION
    • INCLUSIONS & EXCLUSIONS
    • MARKET SCOPE
      • MARKETS COVERED
      • REGIONS COVERED
      • YEARS CONSIDERED
      • CURRENCY CONSIDERED
    • STAKEHOLDERS
    • SUMMARY OF CHANGES
      • RECESSION IMPACT: CARRIER SCREENING MARKET
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET ESTIMATION
      • REVENUE MAPPING-BASED MARKET ESTIMATION
      • GROWTH FORECAST
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • RESEARCH LIMITATIONS
    • MARKET SHARE ANALYSIS
    • STUDY ASSUMPTIONS
    • RISK ASSESSMENT
      • Table RISK ASSESSMENT: CARRIER SCREENING MARKET
    • IMPACT OF ECONOMIC RECESSION ON CARRIER SCREENING MARKET
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • CARRIER SCREENING MARKET OVERVIEW
    • CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2023-2028
    • NORTH AMERICA: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE AND COUNTRY, 2023
    • GEOGRAPHICAL GROWTH OPPORTUNITIES: CARRIER SCREENING MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table GLOBAL INCIDENCE RATE OF TRISOMY
        • Table FERTILITY RATE (BIRTHS PER WOMAN), BY COUNTRY
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
    • TRENDS
      • LACK OF PUBLIC INTEREST IN EXPANDED CARRIER SCREENING
    • PRICING ANALYSIS
      • Table INDICATIVE PRICING OF CARRIER SCREENING PRODUCTS/SERVICES
      • Table AVERAGE SELLING PRICE OF PREIMPLANTATION GENETIC TESTING SYSTEMS
    • VALUE CHAIN ANALYSIS
    • SUPPLY CHAIN ANALYSIS
    • PORTER'S FIVE FORCES ANALYSIS
      • Table PORTER'S FIVE FORCES: CARRIER SCREENING MARKET
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • INTENSITY OF COMPETITIVE RIVALRY
    • ECOSYSTEM/MARKET MAP
      • Table ROLE IN ECOSYSTEM: CARRIER SCREENING MARKET
    • TARIFF & REGULATORY LANDSCAPE
      • Table INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING CARRIER SCREENING MARKET
      • NORTH AMERICA
      • EUROPE
      • ASIA PACIFIC
    • PATENT ANALYSIS
      • PATENT TRENDS FOR CARRIER SCREENING
      • JURISDICTION AND TOP APPLICANT ANALYSIS
    • TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
      • REVENUE SHIFT AND REVENUE POCKETS FOR CARRIER SCREENING MANUFACTURERS
    • KEY CONFERENCES & EVENTS
      • Table DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2024-DECEMBER 2025
    • TECHNOLOGY ANALYSIS
    • KEY STAKEHOLDERS & BUYING CRITERIA
      • KEY STAKEHOLDERS
        • Table INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CARRIER SCREENING PRODUCTS (%)
      • BUYING CRITERIA
        • Table KEY BUYING CRITERIA FOR END USERS OF CARRIER SCREENING PRODUCTS/SERVICES
    • TRADE ANALYSIS
      • Table IMPORT DATA FOR HS CODE 901849, BY COUNTRY, 2018-2022 (USD MILLION)
      • Table EXPORT DATA FOR HS CODE 901849, BY COUNTRY, 2018-2022 (USD MILLION)
  • CARRIER SCREENING MARKET, BY PRODUCT & SERVICE
    • INTRODUCTION
      • Table CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • SERVICES
      • RISING NUMBER OF ACCREDITED LABORATORIES AND GENETIC CASES TO DRIVE MARKET
        • Table CARRIER SCREENING MARKET FOR SERVICES, BY REGION, 2021-2028 (USD MILLION)
    • PRODUCTS
      • GROWING INCIDENCE OF CHROMOSOMAL ABNORMALITIES AND RISING USE OF CARRIER SCREENING TESTS TO DRIVE MARKET
        • Table KEY PLAYERS PROVIDING CARRIER SCREENING PRODUCTS
        • Table CARRIER SCREENING MARKET FOR PRODUCTS, BY REGION, 2021-2028 (USD MILLION)
  • CARRIER SCREENING MARKET, BY TYPE
    • INTRODUCTION
      • Table CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • EXPANDED CARRIER SCREENING
      • Table CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
      • Table CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY REGION, 2021-2028 (USD MILLION)
      • PREDESIGNED PANEL TESTING
        • Table PREDESIGNED PANEL TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
      • CUSTOMIZED PANEL TESTING
        • Table CUSTOMIZED PANEL TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TARGETED DISEASE CARRIER SCREENING
      • INTRODUCTION OF PANELS FOR SIMULTANEOUSLY SCREENING MULTIPLE GENETIC CONDITIONS TO DRIVE MARKET
        • Table CARRIER SCREENING MARKET FOR TARGETED DISEASE CARRIER SCREENING, BY REGION, 2021-2028 (USD MILLION)
  • CARRIER SCREENING MARKET, BY MEDICAL CONDITION
    • INTRODUCTION
      • Table CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
    • PULMONARY CONDITIONS
      • INCREASING AWARENESS ABOUT CYSTIC FIBROSIS IN REPRODUCTIVE PLANNING TO DRIVE MARKET
        • Table LIVE BIRTH INCIDENCE OF CYSTIC FIBROSIS
        • Table CARRIER SCREENING PRODUCTS/SERVICES FOR CYSTIC FIBROSIS
        • Table CARRIER SCREENING MARKET FOR PULMONARY CONDITIONS, BY REGION, 2021-2028 (USD MILLION)
    • HEMATOLOGICAL CONDITIONS
      • RISING PREVALENCE OF HEMATOLOGICAL DISORDERS AMONG INFANTS TO DRIVE MARKET
        • Table CARRIER SCREENING MARKET FOR HEMATOLOGICAL CONDITIONS, BY REGION, 2021-2028 (USD MILLION)
    • NEUROLOGICAL CONDITIONS
      • INCREASED AWARENESS OF NEUROLOGICAL SCREENING AND PRESENCE OF TARGETED SCREENING PANELS TO DRIVE MARKET
        • Table GLOBAL PREVALENCE OF NEUROLOGICAL CONDITIONS
        • Table CARRIER SCREENING PRODUCTS/SERVICES FOR NEUROLOGICAL CONDITIONS
        • Table CARRIER SCREENING MARKET FOR NEUROLOGICAL CONDITIONS, BY REGION, 2021-2028 (USD MILLION)
    • OTHER MEDICAL CONDITIONS
      • Table CARRIER SCREENING MARKET FOR OTHER MEDICAL CONDITIONS, BY REGION, 2021-2028 (USD MILLION)
  • CARRIER SCREENING MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • DNA SEQUENCING
      • DNA SEQUENCING SEGMENT TO DOMINATE MARKET DURING STUDY PERIOD
        • Table DNA SEQUENCING USED BY MARKET PLAYERS
        • Table CARRIER SCREENING MARKET FOR DNA SEQUENCING, BY REGION, 2021-2028 (USD MILLION)
    • PCR
      • HIGH ACCURACY, LOW REACTION TIME, AND ABSOLUTE ESTIMATION OF TARGET MOLECULE TO DRIVE MARKET
        • Table PCR USED BY MARKET PLAYERS
        • Table CARRIER SCREENING MARKET FOR PCR, BY REGION, 2021-2028 (USD MILLION)
    • DNA MICROARRAYS
      • ABILITY TO ANALYZE MULTIPLE GENETIC MARKERS IN SINGLE ASSAY TO DRIVE MARKET
        • Table DNA MICROARRAYS USED BY MARKET PLAYERS
        • Table CARRIER SCREENING MARKET FOR DNA MICROARRAYS, BY REGION, 2021-2028 (USD MILLION)
    • OTHER TECHNOLOGIES
      • Table ADVANTAGES OF OTHER TECHNOLOGIES FOR CARRIER SCREENING
      • Table CARRIER SCREENING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021-2028 (USD MILLION)
  • CARRIER SCREENING MARKET, BY END USER
    • INTRODUCTION
      • Table CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • HOSPITALS AND MEDICAL CENTERS
      • RISING PATIENT POPULATION AND INCREASING MEDICARE REIMBURSEMENT FOR CLINICAL TESTS TO DRIVE SEGMENT
        • Table CARRIER SCREENING MARKET FOR HOSPITALS AND MEDICAL CENTERS, BY REGION, 2021-2028 (USD MILLION)
    • CLINICAL LABORATORIES
      • LOWER SERVICE COSTS AND HIGHER TURNAROUND TIME TO DRIVE MARKET
        • Table CARRIER SCREENING MARKET FOR CLINICAL LABORATORIES, BY REGION, 2021-2028 (USD MILLION)
    • FERTILITY CLINICS
      • INCREASING NUMBER OF INFERTILE COUPLES AND GROWING MEDICAL TOURISM IN EMERGING ECONOMIES TO DRIVE MARKET
        • Table CARRIER SCREENING MARKET FOR FERTILITY CLINICS, BY REGION, 2021-2028 (USD MILLION)
    • OTHER END USERS
      • Table CARRIER SCREENING MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
  • CARRIER SCREENING MARKET, BY REGION
    • INTRODUCTION
      • Table CARRIER SCREENING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: CARRIER SCREENING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • NORTH AMERICA: RECESSION IMPACT
      • US
        • Table US: KEY MACROINDICATORS
        • Table US: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table US: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table US: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
        • Table US: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
      • CANADA
        • Table CANADA: KEY MACROINDICATORS
        • Table CANADA: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table CANADA: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table CANADA: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
        • Table CANADA: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • EUROPE
      • Table EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY (% OF GDP)
      • EUROPE: RECESSION IMPACT
        • Table EUROPE: CARRIER SCREENING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table EUROPE: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table EUROPE: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
        • Table EUROPE: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
      • GERMANY
        • Table GERMANY: KEY MACROINDICATORS
        • Table GERMANY: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table GERMANY: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table GERMANY: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
        • Table GERMANY: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
      • UK
        • Table UK: KEY MACROINDICATORS
        • Table UK: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table UK: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table UK: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
        • Table UK: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
      • FRANCE
        • Table FRANCE: KEY MACROINDICATORS
        • Table FRANCE: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table FRANCE: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table FRANCE: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
        • Table FRANCE: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
      • ITALY
        • Table ITALY: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table ITALY: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table ITALY: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
        • Table ITALY: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
      • SPAIN
        • Table SPAIN: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table SPAIN: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table SPAIN: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
        • Table SPAIN: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
      • REST OF EUROPE
        • Table REST OF EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2021 (% OF GDP)
        • Table REST OF EUROPE: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • ASIA PACIFIC
      • ASIA PACIFIC: RECESSION IMPACT
        • Table ASIA PACIFIC: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
      • INDIA
        • Table INDIA: KEY MACROINDICATORS
        • Table INDIA: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table INDIA: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table INDIA: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
        • Table INDIA: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table INDIA: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
        • Table INDIA: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
      • CHINA
        • Table CHINA: KEY MACROINDICATORS
        • Table CHINA: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table CHINA: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table CHINA: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
        • Table CHINA: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
      • JAPAN
        • Table JAPAN: KEY MACROINDICATORS
        • Table JAPAN: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table JAPAN: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table JAPAN: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
        • Table JAPAN: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table REST OF ASIA PACIFIC: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • REST OF THE WORLD
      • REST OF THE WORLD: RECESSION IMPACT
        • Table REST OF THE WORLD: CARRIER SCREENING MARKET, BY PRODUCT & 2021-2028 (USD MILLION)
        • Table REST OF THE WORLD: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF THE WORLD: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF THE WORLD: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table REST OF THE WORLD: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
        • Table REST OF THE WORLD: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
      • LATIN AMERICA
        • Table DEFINITION OF RARE DISEASES IN VARIOUS COUNTRIES
        • Table LATIN AMERICA: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
      • MIDDLE EAST & AFRICA
        • Table MIDDLE EAST & AFRICA: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: CARRIER SCREENING MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING, BY TYPE, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: CARRIER SCREENING MARKET, BY END USER, 2021-2028 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • KEY STRATEGIES/RIGHT TO WIN
      • OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
        • Table OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CARRIER SCREENING MARKET
    • MARKET SHARE ANALYSIS
      • Table DEGREE OF COMPETITION: CARRIER SCREENING MARKET
    • REVENUE SHARE ANALYSIS
    • COMPANY EVALUATION MATRIX
      • STARS
      • EMERGING LEADERS
      • PERVASIVE PLAYERS
      • PARTICIPANTS
      • COMPANY FOOTPRINT
        • Table OVERALL COMPANY FOOTPRINT
        • Table PRODUCT FOOTPRINT
        • Table REGIONAL FOOTPRINT
    • START-UP/SME EVALUATION MATRIX
      • PROGRESSIVE COMPANIES
      • RESPONSIVE COMPANIES
      • DYNAMIC COMPANIES
      • STARTING BLOCKS
      • COMPETITIVE BENCHMARKING
        • Table DETAILED LIST OF KEY START-UPS/SMES IN CARRIER SCREENING MARKET
    • COMPETITIVE SCENARIOS AND TRENDS
      • KEY DEALS
        • Table KEY DEALS, JANUARY 2020-DECEMBER 2023
  • COMPANY PROFILES
    • KEY PLAYERS
      • NATERA, INC.
        • Table NATERA, INC.: COMPANY OVERVIEW
      • QUEST DIAGNOSTICS INCORPORATED
        • Table QUEST DIAGNOSTICS INCORPORATED: COMPANY OVERVIEW
      • FULGENT GENETICS
        • Table FULGENT GENETICS: COMPANY OVERVIEW
      • INVITAE CORPORATION
        • Table INVITAE CORPORATION: COMPANY OVERVIEW
      • EUROFINS SCIENTIFIC
        • Table EUROFINS SCIENTIFIC: COMPANY OVERVIEW
      • OPKO HEALTH, INC.
        • Table OPKO HEALTH, INC.: COMPANY OVERVIEW
      • THERMO FISHER SCIENTIFIC INC.
        • Table THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
      • MYRIAD GENETICS, INC.
        • Table MYRIAD GENETICS, INC.: COMPANY OVERVIEW
      • ILLUMINA, INC.
        • Table ILLUMINA, INC.: COMPANY OVERVIEW
      • LABORATORY CORPORATION OF AMERICA HOLDINGS
        • Table LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW
      • CENTOGENE N.V.
        • Table CENTOGENE N.V.: COMPANY OVERVIEW
      • DIASORIN S.P.A.
        • Table DIASORIN S.P.A.: COMPANY OVERVIEW
      • BGI
        • Table BGI: COMPANY OVERVIEW
      • OTOGENETICS
        • Table OTOGENETICS: COMPANY OVERVIEW
      • GENETECH
        • Table GENETECH: COMPANY OVERVIEW
    • OTHER PLAYERS
      • OXY-GEN LABORATORY LLC
        • Table OXY-GEN LABORATORY LLC: COMPANY OVERVIEW
      • MEDGENOME
        • Table MEDGENOME: COMPANY OVERVIEW
      • AMBRY GENETICS.
        • Table AMBRY GENETICS: COMPANY OVERVIEW
      • ASPER BIOGENE
        • Table ASPER BIOGENE: COMPANY OVERVIEW
      • LIFELABS GENETICS
        • Table LIFELABS GENETICS: COMPANY OVERVIEW
      • EASYDNA
        • Table EASYDNA: COMPANY OVERVIEW
      • LIFECELL
        • Table LIFECELL: COMPANY OVERVIEW
      • CNC PATH LAB
        • Table CNC PATH LAB: COMPANY OVERVIEW
      • SIGNATURE DIAGNOSTICS INC.
        • Table SIGNATURE DIAGNOSTICS INC.: COMPANY OVERVIEW
      • MITERA
        • Table MITERA: COMPANY OVERVIEW
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • CUSTOMIZATION OPTIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings